Latin Clinical Trial Center

Who We Are
Our Work

Welcome to Latin Clinical Trial Center

Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials. By integrating a leading, private-practice physician network, comprehensive site management and a solid patient recruitment program, LCTC Inc., provides a broad range of services fundamental to executing clinical trials expeditiously and economically. Our mission is to assist pharmaceutical companies and C.R.O.s to successfully bring new studied medication to the marketplace by providing the highest quality and cost effective Clinical Research Trials.

Learn More About US

Trials Status

Ongoing/In Follow Up
June 19, 2019

ELI LILLY (I4V-MC-JADY)

Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Rheumatoid Arthritis
Carlos Sariol 12,945
0
Ongoing/In Follow Up
June 19, 2019

ELI LILLY (I1F-MC-RHBX)

A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients with Nonradiographic Axial Spondyloarthritis
Carlos Sariol 3,806
0
Ongoing/In Follow Up
June 19, 2019

ELI LILLY (I1F-MC-RHBY)

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients with Axial…
Carlos Sariol 28
0
View All Trials